Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
'Steady Bullish' Options Activity in Pfizer (PFE) Ahead of Q4 Earnings Announcement on Jan. 30th -Susquehanna
January 26, 2018 2:39 PM ESTSusquehanna options strategist Alison Edwards notes "steady bullish" options activity in Pfizer (NYSE: PFE) ahead of fourth quarter earnings on Jan. 30th, as investors purchased ~20,000 Feb 38 Calls and 10,000 Feb 38.5 Calls.
... More